AI Portfolio Summary
In 2025 Q4, Boxer Capital Management, LLC maintained a portfolio of 49 distinct positions. The most significant new addition to the portfolio was TERNS PHARMACEUTICAL, which now represents 3.32% of the total fund value. They heavily accumulated shares in TANGO THERAPEUTICS I, increasing their position by 11.3%. Conversely, Boxer Capital Management, LLC completely exited their position in MERUS N V.
Total Positions
49
Quarter
2025 Q4
Top Holding
TNGX (21.1%)
Top 10 Concentration
62.1%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-25 of 49
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
TNGX
TANGO THERAPEUT...
|
Unknown | 21.09% | 26.16% |
#1
Prev: #1
|
10.0 | 1,104,734 | 11.3% |
P
S
|
10,876,219 | $96,363,300 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RVMD
REVOLUTION MEDI...
|
Unknown | 6.97% | 5.95% |
#2
1
Prev: #3
|
2.8 | no change | no change |
P
S
|
400,000 | $31,860,000 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
KOD
KODIAK SCIENCES...
|
Unknown | 6.95% | 3.91% |
#3
2
Prev: #5
|
4.9 | 386,000 | 51.5% |
P
S
|
1,136,000 | $31,762,560 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
KYMR
KYMERA THERAPEU...
|
Unknown | 5.60% | 5.76% |
#4
Prev: #4
|
4.3 | 10,000 | 3.1% |
P
S
|
329,100 | $25,607,271 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CELC
CELCUITY INC
|
Unknown | 4.91% | 1.42% |
#5
13
Prev: #18
|
4.3 | 135,000 | 150.0% |
P
S
|
225,000 | $22,441,500 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ABVX
ABIVAX SA
|
Unknown | 3.69% | 3.25% |
#6
5
Prev: #11
|
3.5 | 5,000 | 4.2% |
P
S
|
125,000 | $16,856,875 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PTCT
PTC THERAPEUTIC...
|
Unknown | 3.33% | 3.91% |
#7
1
Prev: #6
|
1.3 | no change | no change |
P
S
|
200,000 | $15,192,000 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TERN
TERNS PHARMACEU...
|
Unknown | 3.32% | — |
#8
Prev: #—
|
3.3 | 375,000 | no change |
NEW
|
375,000 | $15,150,000 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PTGX
PROTAGONIST THE...
|
Unknown | 3.25% | 2.33% |
#9
3
Prev: #12
|
3.5 | 60,000 | 54.5% |
P
S
|
170,000 | $14,847,800 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PRAX
PRAXIS PRECISIO...
|
Unknown | 3.00% | — |
#10
Prev: #—
|
3.2 | 46,457 | no change |
NEW
|
46,457 | $13,692,736 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
URGN
UROGEN PHARMA L...
|
Unknown | 2.56% | 3.66% |
#11
3
Prev: #8
|
1.1 | -75,000 | -13.0% |
P
S
|
500,000 | $11,710,000 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CDTX
CIDARA THERAPEU...
|
Unknown | 2.56% | 1.47% |
#12
5
Prev: #17
|
3.1 | 5,000 | 10.4% |
P
S
|
53,000 | $11,707,170 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PALI
PALISADE BIO IN...
|
Unknown | 2.47% | — |
#13
Prev: #—
|
3.0 | 4,799,875 | no change |
NEW
|
4,799,875 | $11,279,706 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AMLX
AMYLYX PHARMACE...
|
Unknown | 2.12% | 3.90% |
#14
7
Prev: #7
|
0.9 | -100,000 | -11.1% |
P
S
|
800,000 | $9,664,000 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SRZN
SURROZEN INC
|
Unknown | 2.06% | — |
#15
Prev: #—
|
2.8 | 416,150 | no change |
NEW
|
416,150 | $9,404,990 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CAPR
CAPRICOR THERAP...
|
Unknown | 2.05% | — |
#16
Prev: #—
|
2.8 | 325,000 | no change |
NEW
|
325,000 | $9,379,500 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MNMD
MIND MEDICINE M...
|
Unknown | 1.75% | 0.61% |
#17
7
Prev: #24
|
3.0 | 435,000 | 266.1% |
P
S
|
598,500 | $8,013,915 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
COGT
COGENT BIOSCIEN...
|
Unknown | 1.75% | — |
#18
Prev: #—
|
2.7 | 225,000 | no change |
NEW
|
225,000 | $7,992,000 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
REPL
REPLIMUNE GROUP...
|
Unknown | 1.60% | 1.40% |
#19
Prev: #19
|
0.7 | -300,000 | -28.6% |
P
S
|
750,000 | $7,290,000 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
QURE
UNIQURE NV
|
Unknown | 1.52% | 14.88% |
#20
18
Prev: #2
|
0.8 | -510,000 | -63.7% |
P
S
|
290,000 | $6,939,700 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CYTK
CYTOKINETICS IN...
|
Unknown | 1.39% | 3.50% |
#21
11
Prev: #10
|
0.7 | -100,000 | -50.0% |
P
S
|
100,000 | $6,354,000 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CYBN
CYBIN INC
|
Unknown | 1.28% | — |
#22
Prev: #—
|
2.5 | 715,000 | no change |
NEW
|
715,000 | $5,848,700 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PGEN
PRECIGEN INC
|
Unknown | 1.26% | 0.89% |
#23
1
Prev: #22
|
2.7 | 525,000 | 61.8% |
P
S
|
1,375,000 | $5,747,500 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CTNM
CONTINEUM THERA...
|
Unknown | 1.24% | — |
#24
Prev: #—
|
2.5 | 494,000 | no change |
NEW
|
494,000 | $5,646,420 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
N/A
CRESCENT BIOPHA...
|
—
|
Unknown | 1.18% | 1.72% |
#25
11
Prev: #14
|
0.5 | no change | no change |
P
S
|
453,686 | $5,380,716 | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
MRUS
MERUS N V
|
Unknown | 0.00% | 3.60% |
Sold All 😨
(Was: #9) |
0.3 | -120,000 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NKTR
NEKTAR THERAPEU...
|
Unknown | 0.00% | 2.27% |
Sold All 😨
(Was: #13) |
0.3 | -125,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DNLI
DENALI THERAPEU...
|
Unknown | 0.00% | 1.16% |
Sold All 😨
(Was: #21) |
0.3 | -250,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TIL
INSTIL BIO INC
|
Unknown | 0.00% | 0.35% |
Sold All 😨
(Was: #31) |
0.3 | -60,700 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-25 of 49 holdings